Recent Finacing
Recent Raise
Nexo Therapeutics develops small‑molecule cancer therapies using a CODON covalent‑fragment discovery engine and INFINI‑T chemical biology platform (small‑molecule‑controllable chimeric proteins) to optimize in‑cell and in‑vivo candidates.
